'Prion-like' propagation of mouse and human tau aggregates in an inducible mouse model of tauopathy
- PMID: 20160454
- DOI: 10.1159/000283479
'Prion-like' propagation of mouse and human tau aggregates in an inducible mouse model of tauopathy
Abstract
Background: Aggregates of the tau protein are a hallmark of Alzheimer's and several other neurodegenerative diseases. Various transgenic mouse models have been generated to study the aggregation process. Since wild-type tau is highly soluble and does not aggregate readily, most models make use of tau mutations that occur in human frontotemporal dementias and are more prone to aggregate. These mouse models show neurofibrillary tangles similar to those of Alzheimer's disease. However, since the mice contain both endogenous wild-type mouse tau and exogenous human mutant tau, the relative contribution of these components to the aggregates has been a matter of debate.
Objective: Using a new set of regulatable transgenic mouse models, we sought to determine whether mouse tau coaggregates with human tau when it is switched on. Furthermore, we asked what type of tau remains in the aggregates after switching off the expression of exogenous tau.
Methods: We generated doxycycline-inducible transgenic mice expressing either full-length human tau or the tau repeat domain (tau(RD)). In addition, both types of human tau derivatives were expressed in a 'proaggregant' form (with the frontotemporal dementia with parkinsonism linked to chromosome 17 mutation DeltaK280), or in an 'antiaggregant' form (with additional proline mutations to block beta-structure and aggregation).
Results: The proaggregant tau(RD) mice develop tangles rapidly after induction, the antiaggregant mice do not. Analysis by biochemistry and immunohistology reveals that the tangles contain both exogenous and endogenous mouse tau. After switching off the proaggregant tau(RD), tangles persist for extended periods. However, they are composed entirely of mouse tau.
Conclusions: Mouse tau and exogenous human tau can coaggregate in transgenic models of tauopathy. The aggregates are in dynamic equilibrium with their subunits, so that exogenous tau disappears when its expression is switched off. Once the seeds of aggregation are generated by the foreign tau species, they propagate in a 'prion-like' fashion within the cell even after the foreign tau has disappeared.
Copyright 2010 S. Karger AG, Basel.
Similar articles
-
The potential for beta-structure in the repeat domain of tau protein determines aggregation, synaptic decay, neuronal loss, and coassembly with endogenous Tau in inducible mouse models of tauopathy.J Neurosci. 2008 Jan 16;28(3):737-48. doi: 10.1523/JNEUROSCI.2824-07.2008. J Neurosci. 2008. PMID: 18199773 Free PMC article.
-
A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.Exp Neurol. 2008 Jul;212(1):71-84. doi: 10.1016/j.expneurol.2008.03.007. Epub 2008 Mar 21. Exp Neurol. 2008. PMID: 18490011
-
Characterization of a double (amyloid precursor protein-tau) transgenic: tau phosphorylation and aggregation.Neuroscience. 2005;130(2):339-47. doi: 10.1016/j.neuroscience.2004.09.029. Neuroscience. 2005. PMID: 15664690
-
Deletion of murine tau gene increases tau aggregation in a human mutant tau transgenic mouse model.Biochem Soc Trans. 2010 Aug;38(4):1001-5. doi: 10.1042/BST0381001. Biochem Soc Trans. 2010. PMID: 20658993 Review.
-
Misfolded tau protein and disease modifying pathways in transgenic rodent models of human tauopathies.Acta Neuropathol. 2009 Jul;118(1):71-86. doi: 10.1007/s00401-009-0499-y. Epub 2009 Feb 24. Acta Neuropathol. 2009. PMID: 19238406 Review.
Cited by
-
Pharmacokinetics and metabolism of 2-aminothiazoles with antiprion activity in mice.Pharm Res. 2013 Apr;30(4):932-50. doi: 10.1007/s11095-012-0912-4. Epub 2013 Feb 16. Pharm Res. 2013. PMID: 23417511 Free PMC article.
-
Accumulation of C-terminal cleaved tau is distinctly associated with cognitive deficits, synaptic plasticity impairment, and neurodegeneration in aged mice.Geroscience. 2022 Feb;44(1):173-194. doi: 10.1007/s11357-021-00408-z. Epub 2021 Aug 19. Geroscience. 2022. PMID: 34410588 Free PMC article.
-
Cognitive defects are reversible in inducible mice expressing pro-aggregant full-length human Tau.Acta Neuropathol. 2012 Jun;123(6):787-805. doi: 10.1007/s00401-012-0987-3. Epub 2012 Apr 25. Acta Neuropathol. 2012. PMID: 22532069 Free PMC article.
-
Human Tau isoforms assemble into ribbon-like fibrils that display polymorphic structure and stability.J Biol Chem. 2010 Aug 27;285(35):27302-27313. doi: 10.1074/jbc.M110.145318. Epub 2010 Jun 21. J Biol Chem. 2010. PMID: 20566652 Free PMC article.
-
In vivo microdialysis reveals age-dependent decrease of brain interstitial fluid tau levels in P301S human tau transgenic mice.J Neurosci. 2011 Sep 14;31(37):13110-7. doi: 10.1523/JNEUROSCI.2569-11.2011. J Neurosci. 2011. PMID: 21917794 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous